HR news – Jakob Breuer is the new Chief Technology Officer at Greiner Bio-One GmbH in Frickenhausen
Frickenhausen, 20 June 2018 – Jakob Breuer (51) has become the new Chief Technology Officer (CTO) of the Greiner Bio-One BioScience division in Frickenhausen. Breuer, an engineering graduate, was appointed to the post in April 2018, taking over from Rudi Vollmer, who is retiring after over 40 successful years at the company. As a member of the Greiner Bio-One GmbH management team, Breuer is now responsible for production and technology at this versatile technology partner for the diagnostic and pharmaceutical industries. Management spokesperson Heinz Schmid stays as head of the sales division, and Georg Heftberger remains in charge of commercial and business operations.
Jakob Breuer, who previously had overall management responsibility at an international packaging manufacturer and was technical manager of the European business, is looking forward to the new challenge: „Greiner Bio-One is a cutting-edge high-tech company. I hope my experience in automation and plant optimisation can help successfully shape developments for the future.“
150 years of Greiner!
In 2018, the Greiner Group is celebrating its 150th anniversary. What began in Nürtingen in 1868 with the foundation of a small general store by Carl Albert Greiner and his wife Emilie is today a globally successful family business with over 10,000 employees in 34 countries: https://www.youtube.com/watch?v=0F5DQhxatbs&feature=youtu.be
Greiner Bio-One International GmbH
Greiner Bio-One specialises in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. Greiner Bio-One is split into three divisions – Preanalytics, BioScience and Sterilisation. IAs an Original Equipment Manufacturer (OEM), Greiner Bio-One provides individual solutions in the area of custom-made design developments and production processes for the life sciences and medical sectors. In 2017, Greiner Bio-One International GmbH generated a turnover of 473 million euros and had over 2,200 employees, 26 subsidiaries and numerous distribution partners in over 100 countries. Greiner Bio-One is part of Greiner Holding, which is based in Kremsmünster (Austria).
Greiner Bio-One BioScience Division
The BioScience division of Greiner Bio-One ranks among the leading providers of specialised products for the cultivation and analysis of cell and tissue cultures. Drawing on decades of experience with cryogenic sample storage, Greiner Bio-One also offers solutions for automated storage systems in biobanks. In addition, we continue to utilise our expertise in the development and production of microplates for high-throughput screening, thereby allowing extremely fast and efficient drug screening for both industrial and research applications. The entire development, manufacturing and sales operations are controlled from the German headquarters of the BioScience division in Frickenhausen.
Greiner Bio-One GmbH
Phone: 0049-7022-948 0